Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Int Immunopharmacol. 2011 Dec 22;12(2):368–377. doi: 10.1016/j.intimp.2011.12.009

Figure 9. EF31 shows potent toxicity on NF-κB dependent cancer cell lines.

Figure 9

Cancer cell lines were grown in 96-well plates and treated with curcumin, EF31 (1, 5, 10, or 50 µM), or vehicle (DMSO 1%) for 48 hours. Cell viability/ proliferation was measured as described in section 2.8. Results shown are representative of three separate experiments. All conditions were run in triplicate, and values shown are means (±SEM) expressed as percent of vehicle. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. curcumin at same concentration.